Dapsone Tablet
Product Images NDC 70954-135

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dapsone (NDC 70954-135). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Daspone-100mg-30's Count (Dapsone 100 mg 30s Count)

This is a medication description for Dapsone Tablets USP containing 100 mg of Dapsone per tablet. The recommended dosage instructions are not provided, so it is advised to read the accompanying literature. It also contains instructions to store the drug at room temperature and in a tightly sealed container. The manufacturer, Novitium Pharma LLC, is named along with their address in New Jersey. Finally, it is recommended to keep this medication and all drugs out of reach of children.*

FDA Label Image

Dapsone-25mg-30s-count (Dapsone 25 mg 30s Count)

Each tablet contains 25mg of Dapsone and it is dispensed in a tightly sealed container. The usual dosage is not available in the given text. It is advised to keep this and all drugs away from the reach of children and store them between 20° to 25°C (68° to 77°F). Excursions permitted up to 15° to 30°C (59° to 86°F) [See USP Controlled Rx only BE£S 2 5]. The product's National Drug Code (NDC) is 70954-135-10 and there are 30 tablets per container.*

FDA Label Image

Structure (Dapsone Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.